Skip to content
CancerIndex

Loading the knowledge graph…

A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS Tumors — knowledge graph · CancerIndex